![]() |
市場調查報告書
商品編碼
1625196
2030 年幾丁聚醣市場預測:按來源、形式、等級、應用和地區進行的全球分析Chitosan Market Forecasts to 2030 - Global Analysis By Source (Crustaceans, Shrimp, Crab, Krill, Prawn, Squid, Lobster, and Fungi), Form, Grade, Application and By Geography |
根據 Stratistics MRC 的數據,2024 年全球幾丁聚醣市場規模為 158.9 億美元,預測期內複合年成長率為 22.3%,到 2030 年將達到 532 億美元。
幾丁聚醣是一種源自甲殼素的天然生物聚合物,甲殼素存在於蝦和蟹等甲殼類動物的殼中。它是一種白色、無味、生物分解性的物質,常用於食品、醫藥、農業和化妝品等多種行業。幾丁聚醣因其作為脂肪粘合劑、抗菌劑和天然防腐劑的能力而受到重視。由於其生物相容性,它廣泛應用於創傷治療和藥物傳輸系統等醫療應用。
根據國家漁業發展委員會估計,2020年印度魚類總產量預計為1,260萬噸,其中近65%來自內陸部門,約50%來自水產養殖,約佔6.3%。
擴大在食品和飲料行業中使用
幾丁聚醣被譽為天然防腐劑,有助於延長保存期限並保持食品新鮮,而無需使用合成化學物質。此外,它還可以作為低熱量、無脂肪食品的脂肪替代品,滿足消費者對更健康選擇日益成長的需求。此外,幾丁聚醣也用於機能性食品和營養補充劑,因為它能夠結合脂肪並有助於體重管理。在消費者對天然和永續原料的偏好以及對健康和保健日益關注的推動下,幾丁聚醣在食品包裝和配方中的使用正在急劇發展。
生產成本高
從甲殼動物殼中提取幾丁聚醣需要經過海水淡化、去乙醯和精製等複雜步驟,這增加了生產成本。此外,它需要專門的設備和技術來確保品質和一致性,這會增加成本。它還依賴蝦殼和蟹殼等原料,這可能會給供應鏈帶來挑戰並推高價格。與合成替代品相比,這些高生產成本使得幾丁聚醣產品價格昂貴,並限制了市場滲透,特別是在食品、包裝和藥品等成本敏感的應用中。
製藥應用的增加
幾丁聚醣由於其生物相容性、生物分解性和無毒性而擴大應用於製藥行業。它在藥物傳遞系統中發揮著重要作用,特別是在控制釋放製劑中,有助於提高藥物的生物有效性。此外,幾丁聚醣可促進組織再生並具有抗菌特性,使其可用於創傷治療產品。它還與脂肪結合併降低膽固醇,使其成為體重管理補充劑的關鍵成分。隨著醫學領域對天然、有效和永續解決方案的需求不斷增加,幾丁聚醣的多功能性正在擴大其在該領域的應用。
缺乏消費者意識
消費者缺乏對幾丁聚醣用途和益處的了解是該行業的主要障礙。儘管幾丁聚醣在食品、藥物和農業等領域已廣泛應用,但許多消費者仍擔心其降低膽固醇、幫助減肥以及作為天然防腐劑的潛力,並不清楚其對健康的益處。這種無知限制了它的採用,特別是在開發中國家,消費者可能不知道它在機能性食品和營養保健品中的應用。為了增加市場佔有率並推動成長,有必要讓客戶了解幾丁聚醣的優點,包括其環境效益和對各種應用的適應性。
COVID-19 的影響
COVID-19 的爆發對幾丁聚醣市場產生了各種影響。一方面,全球供應鏈中斷影響了原料的供應,導致生產延誤和成本上升。另一方面,大流行期間人們對健康和保健的興趣增加,增加了對幾丁聚醣等天然成分的需求,特別是在營養補充劑和增強免疫力的產品中。此外,幾丁聚醣在創傷治療和藥物傳輸等健康相關應用中的使用正在增加,其抗菌特性也增加了其需求。整體而言,這場大流行凸顯了永續自然解決方案的重要性,長遠來看有利於市場。
預計食品級細分市場在預測期內將是最大的
由於其天然、安全和多功能的特性,食品級市場預計是最大的市場。隨著消費者健康意識的增強,食品級幾丁聚醣擴大用作脂肪替代品、防腐劑和營養補充劑,特別是在減重產品中。其結合脂肪和降低膽固醇水平的能力進一步增加了幾丁聚醣在機能性食品中的受歡迎程度。此外,食品加工中對天然和永續原料的日益偏好正在支持全球食品產業擴大採用食品級幾丁聚醣。
預計農業部門在預測期內複合年成長率最高
由於農業具有天然生物殺蟲、促進植物生長和土壤肥沃的特性,預計在預測期內複合年成長率最高。幾丁聚醣用於保護作物免受真菌疾病、提高作物產量並刺激植物生長,使其成為化學農藥的環保替代品。隨著永續農業實踐的發展和環境法規的收緊,幾丁聚醣在有機農業和害蟲防治中的作用變得越來越重要。由於幾丁聚醣具有高度生物分解性和安全性,因此受到具有環保意識的農民的青睞,並擴大應用於農業領域。
由於食品、醫藥和農業領域對天然和永續產品的需求不斷成長,預計亞太地區在預測期內將佔據最大的市場佔有率。該地區漁業發達,是甲殼素的穩定來源,甲殼素是生產幾丁聚醣的主要原料。人們對體重管理和降低膽固醇等健康益處的認知不斷提高,也推動了市場的成長。此外,對生態友善有機農業方法的日益關注以及支持永續農業投入的政府法規也推動了該地區幾丁聚醣的採用。
預計北美地區在預測期內的複合年成長率最高。幾丁聚醣因其降低膽固醇和脂肪結合特性而廣泛用於體重管理補充劑、機能性食品和藥品。此外,對環境永續性的日益關注以及向環保包裝和農業實踐的轉變正在推動幾丁聚醣的日益普及。北美市場也受惠於蓬勃的研發活動,有助於幾丁聚醣在食品加工和生物醫學等各行業的創新應用。
根據 Stratistics MRC 的數據,2024 年全球幾丁聚醣市場規模為 158.9 億美元,預測期內複合年成長率為 22.3%,到 2030 年將達到 532 億美元。幾丁聚醣是一種源自甲殼素的天然生物聚合物,甲殼素存在於蝦和蟹等甲殼類動物的殼中。它是一種白色、無味、生物分解性的物質,常用於食品、醫藥、農業和化妝品等多種行業。幾丁聚醣因其作為脂肪粘合劑、抗菌劑和天然防腐劑的能力而受到重視。由於其生物相容性,它廣泛應用於創傷治療和藥物傳輸系統等醫療應用。
根據國家漁業發展委員會估計,2020年印度魚類總產量預計為1,260萬噸,其中近65%來自內陸部門,約50%來自水產養殖,約佔6.3%。
擴大在食品和飲料行業中使用
幾丁聚醣被譽為天然防腐劑,有助於延長保存期限並保持食品新鮮,而無需使用合成化學物質。此外,它還可作為低熱量、無脂肪食品的脂肪替代品,滿足消費者對更健康選擇日益成長的需求。此外,幾丁聚醣也用於機能性食品和營養補充劑,因為它能夠結合脂肪並有助於體重管理。由於消費者對天然和永續原料的偏好以及對健康和保健的日益關注,幾丁聚醣在食品包裝和配方中的使用正在急劇發展。
生產成本高
從甲殼動物殼中提取幾丁聚醣需要海水淡化、去乙醯和精製等複雜步驟,增加了生產成本。此外,它需要專門的設備和技術來確保品質和一致性,這會增加成本。它還依賴蝦殼和蟹殼等原料,這可能會給供應鏈帶來挑戰並推高價格。與合成替代品相比,這些高生產成本使得幾丁聚醣產品價格昂貴,並限制了市場滲透,特別是在食品、包裝和藥品等成本敏感的應用中。
製藥應用的增加
幾丁聚醣由於其生物相容性、生物分解性和無毒性而擴大應用於製藥行業。它在藥物傳遞系統中發揮著重要作用,特別是在控制釋放製劑中,有助於提高藥物的生物有效性。此外,幾丁聚醣可促進組織再生並具有抗菌特性,使其可用於創傷治療產品。它還與脂肪結合併降低膽固醇,使其成為體重管理補充劑的關鍵成分。隨著醫學領域對天然、有效和永續解決方案的需求不斷增加,幾丁聚醣的多功能性正在擴大其在該領域的應用。
缺乏消費者意識
消費者缺乏對幾丁聚醣用途和益處的了解是該行業的主要障礙。儘管幾丁聚醣在食品、醫藥和農業等領域中廣泛應用,但許多消費者仍然對其潛力持懷疑態度,包括降低膽固醇、幫助人們減肥以及作為天然防腐劑,但我不知道它的健康狀況。好處。這種無知限制了它的採用,特別是在開發中國家,消費者可能不知道它在機能性食品和營養保健品中的應用。為了增加市場佔有率並推動成長,有必要讓客戶了解幾丁聚醣的優點,包括其環境效益和對各種應用的適應性。
COVID-19 的影響
COVID-19 的爆發對幾丁聚醣市場產生了各種影響。一方面,全球供應鏈中斷影響了原料的供應,導致生產延誤和成本上升。另一方面,大流行期間人們對健康和保健的興趣增加,增加了對幾丁聚醣等天然成分的需求,特別是在營養補充劑和增強免疫力的產品中。此外,幾丁聚醣在創傷治療和藥物傳輸等健康相關應用中的使用正在增加,其抗菌特性也增加了需求。整體而言,這場大流行凸顯了永續自然解決方案的重要性,長遠來看有利於市場。
預計食品級細分市場在預測期內將是最大的
由於其天然、安全和多功能的特性,食品級市場預計是最大的市場。隨著消費者健康意識的增強,食品級幾丁聚醣擴大用作脂肪替代品、防腐劑和營養補充劑,特別是在減重產品中。其結合脂肪和降低膽固醇水平的能力進一步增加了幾丁聚醣在機能性食品中的受歡迎程度。此外,食品加工中對天然和永續原料的日益偏好正在支持全球食品產業擴大採用食品級幾丁聚醣。
預計農業部門在預測期內複合年成長率最高
由於農業具有天然生物殺蟲、促進植物生長和土壤肥沃的特性,預計在預測期內複合年成長率最高。幾丁聚醣用於保護作物免受真菌疾病、提高作物產量並刺激植物生長,使其成為化學農藥的環保替代品。隨著永續農業實踐的發展和環境法規的收緊,幾丁聚醣在有機農業和害蟲防治中的作用變得越來越重要。由於幾丁聚醣具有高度生物分解性和安全性,因此受到具有環保意識的農民的青睞,並且擴大應用於農業領域。
由於食品、醫藥和農業領域對天然和永續產品的需求不斷成長,預計亞太地區在預測期內將佔據最大的市場佔有率。該地區漁業發達,是甲殼素的穩定來源,甲殼素是生產幾丁聚醣的主要原料。人們對體重管理和降低膽固醇等健康益處的認知不斷提高,也推動了市場的成長。此外,對生態友善有機農業方法的日益關注以及支持永續農業投入的政府法規也推動了該地區幾丁聚醣的採用。
預計北美地區在預測期內的複合年成長率最高。幾丁聚醣因其降低膽固醇和脂肪結合特性而廣泛用於體重管理補充劑、機能性食品和藥品。此外,對環境永續性的日益關注以及向環保包裝和農業實踐的轉變正在推動幾丁聚醣的日益普及。北美市場也受惠於蓬勃的研發活動,有助於幾丁聚醣在食品加工和生物醫學等各行業的創新應用。
According to Stratistics MRC, the Global Chitosan Market is accounted for $15.89 billion in 2024 and is expected to reach $53.20 billion by 2030 growing at a CAGR of 22.3% during the forecast period. Chitosan is a natural biopolymer derived from chitin, which is found in the shells of crustaceans like shrimp and crabs. It is a white, odourless, and biodegradable substance commonly used in various industries, including food, pharmaceuticals, agriculture, and cosmetics. Chitosan is valued for its ability to act as a fat binder, antimicrobial agent, and natural preservative. Due to its biocompatibility, it is widely used in medical applications, such as wound healing and drug delivery systems.
According to The National Fisheries Development Board, in India, total fish production during 2020 was estimated to be 12.60 million metric tons, of which nearly 65% was from the inland sector and about 50% of the total production was from culture fisheries, constituting about 6.3% of the global fish production.
Increasing use in food and beverage industry
Chitosan is valued for its natural preservative properties, helping extend shelf life and maintain food freshness without the need for synthetic chemicals. Additionally, it serves as a fat substitute in low-calorie, fat-free food items, satisfying the increased demand from consumers for healthier options. Furthermore, chitosan has been used into functional foods and nutritional supplements due to its capacity to bind fats and aid in weight management. The use of chitosan in food packaging and formulations is developing dramatically due to consumer preferences for natural, sustainable ingredients and the increased emphasis on health and wellness.
High production costs
The extraction of chitosan from crustacean shells requires a complex process involving demineralization, deacetylation, and purification, which increases production expenses. Additionally, the need for specialized equipment and technology to ensure quality and consistency adds to the cost. The reliance on raw materials, such as shrimp and crab shells, can also create supply chain challenges, further driving up prices. These high production costs make chitosan products more expensive compared to synthetic alternatives, limiting its market penetration in cost-sensitive applications, particularly in industries like food, packaging, and pharmaceuticals.
Rising applications in pharmaceuticals
Chitosan is increasingly used in the pharmaceutical industry due to its biocompatibility, biodegradability, and non-toxic nature. It plays a crucial role in drug delivery systems, particularly in controlled-release formulations, helping to improve the bioavailability of drugs. Additionally, chitosan is utilized in wound healing products, as it accelerates tissue regeneration and has antimicrobial properties. Its ability to bind fat and lower cholesterol also makes it a key ingredient in weight management supplements. As the demand for natural, effective, and sustainable solutions in pharmaceuticals rises, chitosan's versatility is expanding its applications in this sector.
Lack of consumer awareness
Lack of customer knowledge on the uses and advantages of chitosan is a major obstacle in the industry. Despite chitosan's extensive use in sectors like food, medicine, and agriculture, many consumers are not aware of its potential health advantages, which include lowering cholesterol, helping people lose weight, and acting as a natural preservative. Its adoption is restricted by this ignorance, especially in developing nations where consumers might not be aware of its applications in functional foods or nutritional supplements. To increase its market presence and stimulate growth, chitosan must educate customers about its benefits, including its environmental advantages and its adaptability in a variety of applications.
Covid-19 Impact
The COVID-19 pandemic had a mixed impact on the chitosan market. On one hand, the disruption in global supply chains affected the availability of raw materials, leading to delays in production and higher costs. On the other hand, the increased focus on health and wellness during the pandemic boosted the demand for natural ingredients like chitosan, particularly in dietary supplements and immune-boosting products. Additionally, the growing use of chitosan in health-related applications, such as wound healing and drug delivery, saw an uptick due to its antimicrobial properties. Overall, the pandemic highlighted the importance of sustainable, natural solutions, benefiting the market in the long term.
The food grade segment is expected to be the largest during the forecast period
The food grade segment is estimated to be the largest, driven by its natural, safe, and versatile properties. As consumers become more health-conscious, food-grade chitosan is increasingly used as a fat replacer, preservative, and dietary supplement, especially in weight loss products. Its ability to bind fats and reduce cholesterol levels further boosts its popularity in functional foods. Additionally, the rising preference for natural and sustainable ingredients in food processing supports the growing adoption of food-grade chitosan across the global food industry.
The agriculture segment is expected to have the highest CAGR during the forecast period
The agriculture segment is anticipated to witness the highest CAGR during the forecast period, due to its natural biopesticide, plant growth-promoting and soil-enhancing properties. Chitosan is used to protect crops from fungal diseases, improve crop yield, and stimulate plant growth, making it an eco-friendly alternative to chemical pesticides. As sustainable farming practices gain momentum and environmental regulations tighten, chitosan's role in organic farming and pest management becomes increasingly important. Its biodegradability and safety make it a preferred option for eco-conscious farmers, driving its adoption in the agricultural sector.
Asia Pacific is expected to have the largest market share during the forecast period due to growing demand for natural and sustainable products in food, pharmaceuticals, and agriculture. The region's large seafood industry provides a steady supply of chitin, a key raw material for chitosan production. Increasing awareness of health benefits, such as weight management and cholesterol reduction, also fuels market growth. Additionally, the rising focus on eco-friendly and organic farming practices, along with government regulations supporting sustainable agricultural inputs, drives the adoption of chitosan in the region.
During the forecast period, the North America region is anticipated to register the highest CAGR. Chitosan is widely used in weight management supplements, functional foods, and pharmaceuticals due to its cholesterol-lowering and fat-binding properties. Furthermore, the increasing focus on environmental sustainability and the transition to eco-friendly packaging and farming methods is driving greater adoption of chitosan. The North American market also benefits from robust research and development activities, contributing to innovative chitosan applications in various industries, including food processing and biomedicine.
Key players in the market
Some of the key players profiled in the Chitosan Market include KitoZyme SA, Chitosan International, GTC Bio Corporation, Advanced Biopolymers, Primex EHF, Shanghai Jinchang Pharmaceutical Co., Ltd., Green Chem, Heppe Medical Chitosan GmbH, Wako Chemicals USA, Inc., Merit Biotechnology Co., Ltd., Agratech, Taizhou Fuguo Biological Technology Co., Ltd., Tidal Vision, FMC Corporation, Nytt Biotech, Kraton Polymers, PT Biotech Surindo, ChitoTech, Jiangsu Nanjing G & D Pharmaceutical Co., and Shandong Jincheng Biotechnology Co., Ltd.
In June 2024, KitoZyme has partnered with DPH Biologicals, a Belgium-based manufacturer of pharmaceutical-grade fungal chitosan, to develop and commercialize the first sustainably-sourced chitosan seed treatment technology for U.S. growers.
In March 2022, MERIT CRO, Inc., a global clinical trial endpoint service provider focusing on the ophthalmic, respiratory, and oncology therapeutic areas, today announced the launch of its redesigned website.
According to Stratistics MRC, the Global Chitosan Market is accounted for $15.89 billion in 2024 and is expected to reach $53.20 billion by 2030 growing at a CAGR of 22.3% during the forecast period. Chitosan is a natural biopolymer derived from chitin, which is found in the shells of crustaceans like shrimp and crabs. It is a white, odourless, and biodegradable substance commonly used in various industries, including food, pharmaceuticals, agriculture, and cosmetics. Chitosan is valued for its ability to act as a fat binder, antimicrobial agent, and natural preservative. Due to its biocompatibility, it is widely used in medical applications, such as wound healing and drug delivery systems.
According to The National Fisheries Development Board, in India, total fish production during 2020 was estimated to be 12.60 million metric tons, of which nearly 65% was from the inland sector and about 50% of the total production was from culture fisheries, constituting about 6.3% of the global fish production.
Increasing use in food and beverage industry
Chitosan is valued for its natural preservative properties, helping extend shelf life and maintain food freshness without the need for synthetic chemicals. Additionally, it serves as a fat substitute in low-calorie, fat-free food items, satisfying the increased demand from consumers for healthier options. Furthermore, chitosan has been used into functional foods and nutritional supplements due to its capacity to bind fats and aid in weight management. The use of chitosan in food packaging and formulations is developing dramatically due to consumer preferences for natural, sustainable ingredients and the increased emphasis on health and wellness.
High production costs
The extraction of chitosan from crustacean shells requires a complex process involving demineralization, deacetylation, and purification, which increases production expenses. Additionally, the need for specialized equipment and technology to ensure quality and consistency adds to the cost. The reliance on raw materials, such as shrimp and crab shells, can also create supply chain challenges, further driving up prices. These high production costs make chitosan products more expensive compared to synthetic alternatives, limiting its market penetration in cost-sensitive applications, particularly in industries like food, packaging, and pharmaceuticals.
Rising applications in pharmaceuticals
Chitosan is increasingly used in the pharmaceutical industry due to its biocompatibility, biodegradability, and non-toxic nature. It plays a crucial role in drug delivery systems, particularly in controlled-release formulations, helping to improve the bioavailability of drugs. Additionally, chitosan is utilized in wound healing products, as it accelerates tissue regeneration and has antimicrobial properties. Its ability to bind fat and lower cholesterol also makes it a key ingredient in weight management supplements. As the demand for natural, effective, and sustainable solutions in pharmaceuticals rises, chitosan's versatility is expanding its applications in this sector.
Lack of consumer awareness
Lack of customer knowledge on the uses and advantages of chitosan is a major obstacle in the industry. Despite chitosan's extensive use in sectors like food, medicine, and agriculture, many consumers are not aware of its potential health advantages, which include lowering cholesterol, helping people lose weight, and acting as a natural preservative. Its adoption is restricted by this ignorance, especially in developing nations where consumers might not be aware of its applications in functional foods or nutritional supplements. To increase its market presence and stimulate growth, chitosan must educate customers about its benefits, including its environmental advantages and its adaptability in a variety of applications.
Covid-19 Impact
The COVID-19 pandemic had a mixed impact on the chitosan market. On one hand, the disruption in global supply chains affected the availability of raw materials, leading to delays in production and higher costs. On the other hand, the increased focus on health and wellness during the pandemic boosted the demand for natural ingredients like chitosan, particularly in dietary supplements and immune-boosting products. Additionally, the growing use of chitosan in health-related applications, such as wound healing and drug delivery, saw an uptick due to its antimicrobial properties. Overall, the pandemic highlighted the importance of sustainable, natural solutions, benefiting the market in the long term.
The food grade segment is expected to be the largest during the forecast period
The food grade segment is estimated to be the largest, driven by its natural, safe, and versatile properties. As consumers become more health-conscious, food-grade chitosan is increasingly used as a fat replacer, preservative, and dietary supplement, especially in weight loss products. Its ability to bind fats and reduce cholesterol levels further boosts its popularity in functional foods. Additionally, the rising preference for natural and sustainable ingredients in food processing supports the growing adoption of food-grade chitosan across the global food industry.
The agriculture segment is expected to have the highest CAGR during the forecast period
The agriculture segment is anticipated to witness the highest CAGR during the forecast period, due to its natural biopesticide, plant growth-promoting and soil-enhancing properties. Chitosan is used to protect crops from fungal diseases, improve crop yield, and stimulate plant growth, making it an eco-friendly alternative to chemical pesticides. As sustainable farming practices gain momentum and environmental regulations tighten, chitosan's role in organic farming and pest management becomes increasingly important. Its biodegradability and safety make it a preferred option for eco-conscious farmers, driving its adoption in the agricultural sector.
Asia Pacific is expected to have the largest market share during the forecast period due to growing demand for natural and sustainable products in food, pharmaceuticals, and agriculture. The region's large seafood industry provides a steady supply of chitin, a key raw material for chitosan production. Increasing awareness of health benefits, such as weight management and cholesterol reduction, also fuels market growth. Additionally, the rising focus on eco-friendly and organic farming practices, along with government regulations supporting sustainable agricultural inputs, drives the adoption of chitosan in the region.
During the forecast period, the North America region is anticipated to register the highest CAGR. Chitosan is widely used in weight management supplements, functional foods, and pharmaceuticals due to its cholesterol-lowering and fat-binding properties. Furthermore, the increasing focus on environmental sustainability and the transition to eco-friendly packaging and farming methods is driving greater adoption of chitosan. The North American market also benefits from robust research and development activities, contributing to innovative chitosan applications in various industries, including food processing and biomedicine.
Key players in the market
Some of the key players profiled in the Chitosan Market include KitoZyme SA, Chitosan International, GTC Bio Corporation, Advanced Biopolymers, Primex EHF, Shanghai Jinchang Pharmaceutical Co., Ltd., Green Chem, Heppe Medical Chitosan GmbH, Wako Chemicals USA, Inc., Merit Biotechnology Co., Ltd., Agratech, Taizhou Fuguo Biological Technology Co., Ltd., Tidal Vision, FMC Corporation, Nytt Biotech, Kraton Polymers, PT Biotech Surindo, ChitoTech, Jiangsu Nanjing G & D Pharmaceutical Co., and Shandong Jincheng Biotechnology Co., Ltd.
In June 2024, KitoZyme has partnered with DPH Biologicals, a Belgium-based manufacturer of pharmaceutical-grade fungal chitosan, to develop and commercialize the first sustainably-sourced chitosan seed treatment technology for U.S. growers.
In March 2022, MERIT CRO, Inc., a global clinical trial endpoint service provider focusing on the ophthalmic, respiratory, and oncology therapeutic areas, today announced the launch of its redesigned website.